MARY KARIS: Open Payments
NPI 1790448355 · HUMMELSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$386 in 20 payments from 10 companies in 2025. Trend: 2023 $104 · 2024 $415 · 2025 $386
Food & beverage: $386
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $107 |
| Lilly USA, LLC | 3 | $67 |
| Novo Nordisk Inc | 3 | $66 |
| ABBVIE INC. | 2 | $40 |
| Exact Sciences Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| CeQur Corporation | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: AIRSUPRA, MOUNJARO, Ozempic, UBRELVY, JARDIANCE, Wegovy, Cologuard Collection Kit, Kerendia.
Industry payments across PA — which companies pay providers there.
